A detailed history of Advisor Group Holdings, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5,096 shares of ASRT stock, worth $4,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,096
Previous 4,896 4.08%
Holding current value
$4,382
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.07 - $1.75 $214 - $350
200 Added 4.08%
5,096 $6,000
Q2 2024

Aug 13, 2024

SELL
$0.75 - $1.31 $14,133 - $24,685
-18,844 Reduced 79.38%
4,896 $6,000
Q1 2024

May 10, 2024

BUY
$0.79 - $1.14 $16,936 - $24,439
21,438 Added 931.28%
23,740 $22,000
Q4 2023

Feb 12, 2024

SELL
$1.02 - $2.57 $21,749 - $54,800
-21,323 Reduced 90.26%
2,302 $2,000
Q3 2023

Nov 13, 2023

SELL
$2.52 - $5.69 $20,669 - $46,669
-8,202 Reduced 25.77%
23,625 $60,000
Q2 2023

Aug 10, 2023

SELL
$5.0 - $7.66 $50,935 - $78,032
-10,187 Reduced 24.25%
31,827 $172,000
Q1 2023

May 12, 2023

BUY
$3.54 - $6.66 $58,710 - $110,456
16,585 Added 65.22%
42,014 $267,000
Q4 2022

Feb 10, 2023

BUY
$2.11 - $4.3 $51,273 - $104,490
24,300 Added 2152.35%
25,429 $109,000
Q3 2022

Nov 14, 2022

SELL
$2.13 - $4.0 $23,004 - $43,200
-10,800 Reduced 90.54%
1,129 $2,000
Q2 2022

Aug 10, 2022

SELL
$1.88 - $3.42 $2,444 - $4,446
-1,300 Reduced 9.83%
11,929 $35,000
Q1 2022

May 04, 2022

BUY
$2.06 - $3.0 $26,258 - $38,241
12,747 Added 2644.61%
13,229 $38,000
Q3 2021

Nov 05, 2021

BUY
$0.89 - $1.55 $47 - $82
53 Added 12.35%
482 $0
Q2 2021

Aug 02, 2021

BUY
$1.48 - $2.88 $634 - $1,235
429 New
429 $1,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $41.4M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.